CGP 52608

Source: Wikipedia, the free encyclopedia.
CGP 52608
Names
IUPAC name
3-Methyl-1-[(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea
Identifiers
3D model (
JSmol
)
ChemSpider
UNII
  • InChI=1/C8H12N4OS2/c1-3-4-12-6(13)5-15-8(12)11-10-7(14)9-2/h3H,1,4-5H2,2H3,(H2,9,10,14)/b11-8-
    Key: DDYJDIHOSRTMSE-FLIBITNWBI
  • S=C(N\N=C1/SCC(=O)N1C\C=C)NC
Properties
C8H12N4OS2
Molar mass 244.33 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

CGP 52608 is a selective

clinical trials for rheumatoid arthritis, but development was discontinued in 2006.[3]

CGP 52608 contains a thiazolinidinedione group.[4]

References

  1. ^
    PMID 7885826
    .
  2. .
  3. ^ "CGP 52608". Adis Insight.
  4. S2CID 6461798
    .

External links